Skip to main content

Closed

ANIX: Anixa Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-79.6%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio9.79×

Anixa Biosciences, Inc.

ANIXNASDAQ Capital Market·USD·Closed

Anixa Biosciences, Inc.

ANIXNASDAQ·USD·Closed

$3.42

−3.93%

$3.42

−$0.14 (3.93%)

52W Range

35thpctl

Volume

0.80×avg

Mkt Cap

116.36MUSD

P/E

-11.5TTM

Div Yield

–ann

52W Range

35thpctl

Volume

0.80×avg

Market Cap

116.36MUSD

P/E Ratio

-11.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings